Weller et al., 1982 - Google Patents
Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5' …Weller et al., 1982
View PDF- Document ID
- 17578317365050197130
- Author
- Weller I
- Bassendine M
- Craxi A
- Fowler M
- Monjardino J
- Thomas H
- Sherlock S
- Publication year
- Publication venue
- Gut
External Links
Snippet
In eight HBs and HBe antigen positive patients with chronic active liver disease, adenine arabinoside 5'-monophosphate (ARA-AMP) given, intravenously or intramuscularly, six or 12 hours, produced inhibition of viral replication. In five patients given a short course of therapy …
- 101700052274 HBEAG 0 title abstract description 30
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse Transcribing DNA Viruses
- C12N2730/00011—Reverse Transcribing DNA Viruses
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Weller et al. | Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP). | |
| Lai et al. | Detection of hepatitis B virus DNA and RNA in kidneys of HBV-related glomerulonephritis | |
| International Interferon-α Hepatocellular Carcinoma Study Group | Effect of interferon-α on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study | |
| Mondelli et al. | Mechanisms of liver cell injury in acute and chronic hepatitis B | |
| Santantonio et al. | Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine | |
| Lok et al. | Contribution of low level HBV replication to continuing inflammatory activity in patients with anti-HBe positive chronic hepatitis B virus infection. | |
| Lee et al. | In vitro and in vivo comparison of the abilities of purine and pyrimidine 2', 3'-dideoxynucleosides to inhibit duck hepadnavirus | |
| Weller et al. | Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection. | |
| Verme et al. | Role of hepatitis delta virus infection in hepatocellular carcinoma | |
| Valaydon et al. | The role of tumour necrosis factor in hepatitis B infection: Jekyll and Hyde | |
| Feitelson et al. | New animal models of hepatitis B and C | |
| Dienstag | Hepatitis B as an immune complex disease | |
| Ichiki et al. | Propylthiouracil-induced severe hepatitis: a case report and review of the literature | |
| Kingham et al. | Treatment of HBsAg-positive chronic active hepatitis with human fibroblast interferon. | |
| Ponzetto et al. | Serial passage of hepatitis delta virus in chronic hepatitis B virus carrier chimpanzees | |
| US4140761A (en) | Modification of hepatitis B virus infection in chronic carriers of hepatitis B surface antigen | |
| Thomas et al. | Approaches to the treatment of hepatitis B virus and delta-related liver disease | |
| David et al. | Recurrence of hepatitis D (delta) in liver transplants: histopathological aspects | |
| Krogsgaard et al. | Hepatitis B virus DNA, HBeAg and delta infection during the course from acute to chronic hepatitis B virus infection | |
| Barbaro et al. | Intravenous recombinant interferon-beta versus interferon-alpha-2b and ribavirin in combination for short-term treatment of chronic hepatitis C patients not responding to interferon-alpha | |
| Lavine et al. | Persistent hepatitis B virus following interferon alfa therapy and liver transplantation | |
| Ishiwata et al. | Protection against concanavalin A‐induced murine liver injury by the organic germanium compound, propagermanium | |
| Fagan et al. | Persistence of free HBV DNA in body secretions and liver despite loss of serum HBV DNA after interferon‐induced seroconversion | |
| Anderson et al. | Randomised controlled trial of lymphoblastoid interferon for chronic active hepatitis B. | |
| Haritani et al. | Effect of 3′‐azido‐3′‐deoxythymidine on replication of duck hepatitis B virus in vivo and in vitro |